Science Explorer Back to mapMap
Discussion
Topic · Oncology

Bone health and treatments

Bone health and treatments is a research topic within Oncology. Science Explorer counts 43k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the use of bisphosphonates in the treatment of bone metastases and associated complications, particularly osteonecrosis of the jaw. It explores the mechanisms of action, clinical features, and therapeutic opportunities for bisphosphonates in cancer treatment, with a specific emphasis on prostate and breast cancer. The papers also discuss the role of bisphosphonates in maintaining bone health and preventing skeletal complications in cancer patients.

  • Bisphosphonates
  • Osteonecrosis of the Jaw
  • Bone Metastasis
  • Cancer Treatment
  • Skeletal Complications
  • Mechanism of Action
  • Metastatic Bone Disease
  • Clinical Practice Guidelines
  • Prostate Cancer
  • Breast Cancer
Research works
43k
fractional, since 1950
In the world top 10%
4.3k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-7%
the tick is no change
Largest producer
United States
27% of the 10 largest, 2022-now

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Bone health and treatments research?

By volume, the United States and China publish the most (1.1k and 938 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.1k works
  2. 2 China 938 works
  3. 3 Japan 418 works
  4. 4 India 302 works
  5. 5 Italy 238 works
  6. 6 United Kingdom 217 works
  7. 7 Germany 205 works
  8. 8 Brazil 183 works
  9. 9 South Korea 177 works
  10. 10 Türkiye 164 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 27.3%China: 24.0%Japan: 10.7%India: 7.7%6 others listed: 30.3%27%largest
United States1,068 · 27.3%China938 · 24.0%Japan418 · 10.7%India302 · 7.7%6 others listed1,185 · 30.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Bone health and treatments research?

By volume in 2022-now, Harvard University publishes the most Bone health and treatments research, followed by Shanghai Jiao Tong University and Sichuan University.

Who are the leading researchers in Bone health and treatments?

The most-cited researchers publishing on Bone health and treatments include Freddie Bray, George Davey Smith and Walter Churchill Willett.

  1. 1 Freddie Bray France 550k citations
  2. 2 George Davey Smith United Kingdom 435k citations
  3. 3 Walter Churchill Willett United States 411k citations
  4. 4 Hermann Brenner Germany 343k citations
  5. 5 Shizuo Akira Japan 342k citations
  6. 6 Cyrus Cooper United Kingdom 342k citations
  7. 7 Jun Wang China 340k citations
  8. 8 Giuseppe Remuzzi Italy 328k citations
  9. 9 John P. A. Ioannidis United States 317k citations
  10. 10 Graeme J. Hankey Australia 316k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Bone health and treatments?

The most cited paper in Bone health and treatments is "Osteoclast differentiation and activation" (William J. Boyle, W. Scott Simonet, David L. Lacey, 2003), with 6,707 citations. Next come "Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation" (5,491) and "Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy" (4,645).

Most cited papers
#PaperReleasedCitations
1 Osteoclast differentiation and activation William J. Boyle, W. Scott Simonet, David L. Lacey · Nature May 2003 6,707
2 Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation David L. Lacey et al. · Cell Open access Apr 1998 5,491
3 Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy Howard I. Scher, Karim S. Fizazi, Fred Saad et al. · New England Journal of Medicine Open access 15 Aug 2012 4,645
4 Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis Robert M. Neer, Claude D. Arnaud, José Zanchetta et al. · New England Journal of Medicine 10 May 2001 4,604
5 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Hisataka Yasuda, Nobuyuki Shima, Nobuaki NAKAGAWA et al. · Proceedings of the National Academy of Sciences Open access 31 Mar 1998 4,281
All 100 most cited papers, with filters and sorting

Where is Bone health and treatments research done?

The largest centres of Bone health and treatments research in 2022-now are Beijing (China), Tokyo (Japan), Seoul (South Korea) and Shanghai (China).

Largest cities, 2022-now

  1. 1 BeijingChina 112 works
  2. 2 TokyoJapan 100 works
  3. 3 SeoulSouth Korea 86 works
  4. 4 ShanghaiChina 83 works
  5. 5 MoscowRussia 62 works
  6. 6 GuangzhouChina 57 works
  7. 7 São PauloBrazil 55 works
  8. 8 New YorkUnited States 55 works
  9. 9 LondonUnited Kingdom 55 works
  10. 10 ParisFrance 53 works
See Bone health and treatments on the map

Where is the best place to study Bone health and treatments?

Among universities, judged by research, Harvard University, Zhejiang University and Soochow University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 22.07%fractional works in this field (log) →share of work in the world top 10% →Zhejiang UniversitySichuan UniversitySoochow UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 69.715.8%2.9×46 -9.7%
2Zhejiang UniversityChina 63.125.2%1.6×21 +14.0%
3Soochow UniversityChina 58.722.1%3.4×16 +18.9%
4Sichuan UniversityChina 58.423.7%2.6×29 -14.2%
5Central South UniversityChina 53.931.6%1.6×15 -3.1%
6Shanghai Jiao Tong UniversityChina 53.419.4%2.0×29 -28.7%
7Xi'an Jiaotong UniversityChina 52.632.0%1.1×10 +55.0%
8Peking UniversityChina 51.613.5%2.7×27 +3.5%
9University of Arkansas for Medical SciencesUnited States 51.515.9%11.2×8 +10.0%
10University of SheffieldUnited Kingdom 49.721.5%4.8×12 -57.1%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Bone health and treatments, country by country

Is Bone health and treatments research growing?

Output in 2022-2025 was 7% lower than in 2018-2021, peaking in 2013.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Bone health and treatments as a percentage of every work published that year, 0.024% in 2024.

still counting0.025%0.050%0.075%Bone health and treatments0.023% in 202519801990200020102020

Fractional works of Bone health and treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Bone health and treatments10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Bone health and treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.